News

Hims & Hers Health (NYSE: HIMS), the telehealth company famous for selling Ozempic lookalikes over the internet, is tumbling ...
UnitedHealth is deeply undervalued, trading at low P/E and P/FCF multiples despite long-term growth potential and a wide ...
The company assessed goodwill for impairment and recorded a $77 million noncash impairment charge in the pain management and ...
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for ...
Chorus Aviation Inc (TSX:CHR) is set to release its Q2 2025 earnings on August 6, 2025. The consensus estimate for Q2 2025 ...
Caterpillar Inc. (CAT) is preparing for tighter margins in the second half of 2025 as CEO Joseph Creed emphasized that new ...
Investor's Business Daily on MSN41m
Leidos Breaks Out On Earnings, Lifted Outlook
L eidos stock broke out above an entry early Tuesday after the defense and aerospace technology company topped estimates for Q2 results. Leidos reported a 22% increase in earnings to a record $3.21 ...
Pfizer stock rose after the drugmaker posted adjusted earnings came in at 78 cents a share on revenue of $14.7 billion, ...